TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35285906

Group type: EXPERIMENTAL
Intervention: 1.50 g · kg‐1 · d‐1 protein plus multinutrient beverage (NUT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.900 g · kg‐1 · d‐1 protein plus placebo (PLA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NUT
Number of subjects: 20

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 20
Study: 35717385

Group type: EXPERIMENTAL
Intervention: Brief counselling strategies for smoking cessation and risky alcohol consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief counselling strategies
Number of subjects: 0
Study: 33311789

Group type: EXPERIMENTAL
Intervention: Thunderbeat™ device during the Whipple procedure
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 32
Study: 35181552

Group type: EXPERIMENTAL
Intervention: Dynamic Spatial Filtering (DSF)
Number of subjects: 4100

Group type: COMPARATOR
Intervention: Baseline models
Number of subjects: 4100
Study: 33381794

Group type: EXPERIMENTAL
Intervention: Glucose supplementation 3 times daily
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fructose supplementation 3 times daily
Number of subjects: 44
Study: 33203954

Group type: EXPERIMENTAL
Intervention: ASP4345 (3, 15, 50, and 150 mg; n = 9 each dose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ASP4345
Number of subjects: 48
Study: 33345794

Group type: EXPERIMENTAL
Intervention: Customized low-glycemic index diet (n=139 women; 1800 kcal/d + 30 minutes walking 4 times/wk)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Standard care (generic lifestyle advice; n=134 women)
Number of subjects: 273
Study: 36368259

Group type: EXPERIMENTAL
Intervention: Housing + support services
Number of subjects: 240

Group type: COMPARATOR
Intervention: Housing-only
Number of subjects: 240

Group type: COMPARATOR
Intervention: Services as usual (SAU)
Number of subjects: 240
Study: 33317824

Group type: EXPERIMENTAL
Intervention: Phototherapy (PT) devices provided to hospitals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard PT (irradiance < 30 µW/cm2/nm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunlight treatment
Number of subjects: 0
Study: 33935152

Group type: EXPERIMENTAL
Intervention: Digital therapy group (12-week home-based digitally assisted rehabilitation program with 13 face-to-face sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional therapy group (30 sessions of conventional face-to-face physical therapy)
Number of subjects: 50
Study: 35586820

Group type: EXPERIMENTAL
Intervention: Warming Yang, tonifying kidney, and removing arthralgia therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (standard treatment not specified)
Number of subjects: 72
Study: 33272036

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 35668532

Group type: EXPERIMENTAL
Intervention: 3-week multimodal, individualized prehabilitation program including exercise therapy, nutritional intervention, mobility or balance training, and psychosocial interventions and medical assessment, supervised 5 times/week for 3 weeks.
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Shared decision-making process with the patient, relatives, and an interdisciplinary and interprofessional team.
Number of subjects: 1400
Study: 32846841

Group type: EXPERIMENTAL
Intervention: Bidirectional barbed suture (Stratafix1-0 for joint capsule, Stratafix2-0 for subcutaneous, Stratafix3-0 for intracutaneous)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional absorbable suture (Ethicon VICRYL* Plus 1-0 for joint capsule, Ethicon VICRYL* Plus 2-0 for subcutaneous, staples for skin)
Number of subjects: 100
Study: 36138517

Group type: EXPERIMENTAL
Intervention: Caplacizumab + TPE + IST
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo + TPE + IST
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Caplacizumab for recurrence
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Caplacizumab for second recurrences
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 104
Study: 34282568

Group type: EXPERIMENTAL
Intervention: S. salivarius BLIS K12
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35754090

Group type: EXPERIMENTAL
Intervention: Holding Hands Young Parents (HHYP) intervention
Number of subjects: 4
Study: 34488799

Group type: EXPERIMENTAL
Intervention: Multi-parametric Multivariate Random Forest (MM-RF) model
Number of subjects: 116

Group type: COMPARATOR
Intervention: Clinical visual analysis
Number of subjects: 116
Study: 33011010

Group type: EXPERIMENTAL
Intervention: Family-level obesity-targeted intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Referral to community services (control)
Number of subjects: 280
Study: 34664106

Group type: EXPERIMENTAL
Intervention: CAF-6 (6 mg/kg caffeine)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CAF-3 (3 mg/kg caffeine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON (no supplementation)
Number of subjects: 12

Group type: COMPARATOR
Intervention: PLAC (placebo)
Number of subjects: 12
Study: 34662382

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 1064

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 1064
Study: 32589244

Group type: COMPARATOR
Intervention: Analgesic treatment only (Group A)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy and analgesic treatment (Group B)
Number of subjects: 114
Study: 33734529

Group type: EXPERIMENTAL
Intervention: Pilot or feasibility study consent process
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic misconception and therapeutic misestimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Communication in consent process
Number of subjects: 0
Study: 33068791

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a prescribed dose of 35 Gy in five fractions
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 38
Study: 34167891

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz left/bilateral)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study: 34030726

Group type: EXPERIMENTAL
Intervention: Atazanavir in hair
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atazanavir in hair with adequate adherence, normal BMI-for-age, and mature guardians
Number of subjects: 0
Study: 32415664

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 162

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 162
Study: 34414801

Group type: EXPERIMENTAL
Intervention: Take Charge intervention (one or two sessions)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control (no Take Charge sessions)
Number of subjects: 400
Study: 33413311

Group type: EXPERIMENTAL
Intervention: IV iron therapy (4 weeks before surgery)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Autologous whole blood therapy (2 units collected 4 and 2 weeks before surgery)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: IV iron therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Autologous whole blood therapy
Number of subjects: 64
Study: 33194963

Group type: EXPERIMENTAL
Intervention: Gliclazide-based intensive glucose control (IGC)
Number of subjects: 11140

Group type: COMPARATOR
Intervention: Standard glucose control (SGC)
Number of subjects: 11140
Study: 36058135

Group type: EXPERIMENTAL
Intervention: Food response inhibition and attention training
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo control training protocol with non-food images
Number of subjects: 179
Study: 36000037

Group type: EXPERIMENTAL
Intervention: High-dose intranasal desmopressin (40 μg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low-dose intranasal desmopressin (20 μg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32380428

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33156447

Group type: EXPERIMENTAL
Intervention: PPI treatment
Number of subjects: 79
Study: 35321754

Group type: EXPERIMENTAL
Intervention: Full intervention (theatre workshop + self-management workshops)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Theatre only
Number of subjects: 358

Group type: COMPARATOR
Intervention: Usual care (controls)
Number of subjects: 358
Study: 33394523

Group type: EXPERIMENTAL
Intervention: Early e-cigarette users (at 13-14 years)
Number of subjects: 3289

Group type: EXPERIMENTAL
Intervention: Late e-cigarette users (at 14-15 years)
Number of subjects: 3289
Study: 35820631

Group type: EXPERIMENTAL
Intervention: Leptin administration at physiological replacement doses during fasting (study 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Leptin administration at supraphysiological and pharmacological doses during fasting (study 2)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Leptin treatment for two months in hypoleptinemic men with HIV (study 3)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo during fasting (study 1)
Number of subjects: 37
Study: 33142037

Group type: EXPERIMENTAL
Intervention: Sinbaglustat (10 to 2000 mg single doses; 30 to 1000 mg twice daily for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 35723814

Group type: EXPERIMENTAL
Intervention: Ruyi Zhenbao Pills (RZPs) for 4 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34078362

Group type: EXPERIMENTAL
Intervention: Walking Away Plus (WAP)
Number of subjects: 1366

Group type: EXPERIMENTAL
Intervention: Walking Away (WA)
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Control (information leaflet)
Number of subjects: 1366
Study: 32245522

Group type: EXPERIMENTAL
Intervention: Individually randomized controlled trials (RCTs)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cluster randomized controlled trials (CRTs)
Number of subjects: 200
Study: 35867804

Group type: EXPERIMENTAL
Intervention: istaroxime 1.0‐1.5 μg/kg/min
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 32898271

Group type: EXPERIMENTAL
Intervention: Recombinant HA vaccine (rHA)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Egg-derived inactivated influenza vaccine (IIV)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Cell-derived inactivated influenza vaccine (IIV)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 133
Study: 35913888

Group type: EXPERIMENTAL
Intervention: Sutures alone
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Sutures and adhesive tape
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Sutures and tissue adhesive
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 295
Study: 33991711

Group type: EXPERIMENTAL
Intervention: Anti-VEGF injections (as-needed regimen)
Number of subjects: 393
Study: 33176394

Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy (RT), 26 sessions, twice a week for 13 weeks
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 251
Study: 33933742

Group type: EXPERIMENTAL
Intervention: Individualised nutritional support
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Usual hospital food
Number of subjects: 1943
Study: 36347152

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention in addition to conventional physiotherapy and CPM equipment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional physiotherapy and CPM equipment (Control group)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups (including VR and Control)
Number of subjects: 55
Study: 32522066

Group type: EXPERIMENTAL
Intervention: Refined Deep Seawater (RDSW) for 8 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 33745859

Group type: EXPERIMENTAL
Intervention: Vascular Surgery (VS) Letters
Number of subjects: 198

Group type: COMPARATOR
Intervention: Ob/Gyn Letters
Number of subjects: 198
Study: 34358954

Group type: EXPERIMENTAL
Intervention: Basal diet supplemented with 300 mg glycerol monolaurate/kg
Number of subjects: 180

Group type: COMPARATOR
Intervention: Corn-soybean meal based diet
Number of subjects: 180
Study: 33273441

Group type: EXPERIMENTAL
Intervention: Good muscle health grade 'A' (GC≤2 and PL-CSA/BMI≥130)
Number of subjects: 308
Study: 34840945

Group type: EXPERIMENTAL
Intervention: e-Yoga intervention administered via e-Yoga modalities
Number of subjects: 135
Study: 33373666

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Vigorous-moderate exercise
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study: 36320174

Group type: EXPERIMENTAL
Intervention: Betahistine 24 mg every 12 h for 90 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo tablets every 12 h for 90 days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Betahistine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Betahistine and Control
Number of subjects: 62
Study: 33078561

Group type: EXPERIMENTAL
Intervention: M-CHAT/F screening for ASD
Number of subjects: 3343

Group type: EXPERIMENTAL
Intervention: Hospital diagnosis process initiation
Number of subjects: 3343

Group type: EXPERIMENTAL
Intervention: Loss-to-follow-up during hospital diagnosis process
Number of subjects: 3343
Study: 32517521

Group type: EXPERIMENTAL
Intervention: Chores, errands, and work (for girls)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Play (for boys)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Chores, errands, and work (public vs private school girls)
Number of subjects: 395
Study: 34111588

Group type: EXPERIMENTAL
Intervention: Time to positivity (TTP) for Candida spp.
Number of subjects: 3462

Group type: EXPERIMENTAL
Intervention: Time to positivity (TTP) for streptococci.
Number of subjects: 3462

Group type: EXPERIMENTAL
Intervention: Fever
Number of subjects: 3462

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3462

Group type: EXPERIMENTAL
Intervention: Neutrophilia
Number of subjects: 3462
Study: 34098667

Group type: EXPERIMENTAL
Intervention: COPD+periodontitis group
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Periodontitis group
Number of subjects: 138
Study: 36118838

Group type: EXPERIMENTAL
Intervention: Individualized nursing based on MDT concept
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 110
Study: 32736909

Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at sea level
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at sea level
Number of subjects: 8

Group type: COMPARATOR
Intervention: No Singing (NS) at sea level
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at 3000 m
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at 3000 m
Number of subjects: 8

Group type: COMPARATOR
Intervention: No Singing (NS) at 3000 m
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Singing Aloud (SA) at 5000 m
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Singing Silently (SS) at 5000 m
Number of subjects: 8

Group type: COMPARATOR
Intervention: No Singing (NS) at 5000 m
Number of subjects: 8
Study: 35738869

Group type: EXPERIMENTAL
Intervention: Programmed and directed physical exercise (PDPE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 33854039

Group type: EXPERIMENTAL
Intervention: Metformin 1500 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32120198

Group type: EXPERIMENTAL
Intervention: eCHECKUPTOGO-marijuana (BI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control condition (CTL)
Number of subjects: 49
Study: 36153858

Group type: EXPERIMENTAL
Intervention: DW1601
Number of subjects: 204

Group type: COMPARATOR
Intervention: DW16011
Number of subjects: 204

Group type: COMPARATOR
Intervention: P. sidoides
Number of subjects: 204
Study: 34040690

Group type: EXPERIMENTAL
Intervention: Only sealer (S)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-cone technique with gutta-percha (GP-S)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BioRoot™ RCS
Number of subjects: 80

Group type: COMPARATOR
Intervention: EndoSequence® BC Sealer™
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Powder-liquid bioceramic sealers (BioRoot™ RCS and ProRoot® ES)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ProRoot® ES
Number of subjects: 80

Group type: COMPARATOR
Intervention: Premixed sealer (EndoSequence® BC Sealer™)
Number of subjects: 80
Study: 34923177

Group type: EXPERIMENTAL
Intervention: Breakfast in the Classroom (BIC) initiative
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Control (breakfast served in the cafeteria before school)
Number of subjects: 1362
Study: 35717595

Group type: EXPERIMENTAL
Intervention: ECHO (carer skills intervention) added to treatment as usual (TAU)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 149
Study: 33597136

Group type: EXPERIMENTAL
Intervention: Yoghurt consumption
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Increased physical activity (daily walking)
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Yoghurt + Physical Activity
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: All interventions (Yoghurt, PA, Yoghurt + PA)
Number of subjects: 1856
Study: 32943858

Group type: EXPERIMENTAL
Intervention: Interdisciplinary home rehabilitation for a maximum of 10 weeks
Number of subjects: 205

Group type: COMPARATOR
Intervention: In-hospital geriatric care
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Interdisciplinary home rehabilitation
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Dementia
Number of subjects: 205
Study: 35363874

Group type: EXPERIMENTAL
Intervention: E-cigarettes for 8 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Assessment-only group
Number of subjects: 240
Study: 33794781

Group type: EXPERIMENTAL
Intervention: 5A online tutorial for general practitioners
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (usual treatment)
Number of subjects: 160
Study: 32114331

Group type: EXPERIMENTAL
Intervention: smartteen (cCBT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 21
Study: 33722758

Group type: EXPERIMENTAL
Intervention: Greedy Rabbit exergame (experimental group, n = 41)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo version of Greedy Rabbit (control group, n = 19)
Number of subjects: 60
Study: 32900508

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 μg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (15 mg isobaric bupivacaine 0.5% with 0.5 ml normal saline 0.9%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 36694242

Group type: EXPERIMENTAL
Intervention: Educational material and SMS reminders
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard of care (weekly pick-up with monthly check-ups)
Number of subjects: 300
Study: 33638741

Group type: EXPERIMENTAL
Intervention: Screw augmentation with bone cement
Number of subjects: 8

Group type: COMPARATOR
Intervention: No screw augmentation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Augmented screws
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nonaugmented screws
Number of subjects: 8
Study: 32546646

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg
Number of subjects: 383

Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 383
Study: 35664249

Group type: EXPERIMENTAL
Intervention: Ideal Protein (IP) Phase I diet
Number of subjects: 192

Group type: COMPARATOR
Intervention: Low-calorie/low-fat (LCLF) diet
Number of subjects: 192
Study: 34495285

Group type: EXPERIMENTAL
Intervention: Online 1-day cognitive behavioral therapy (CBT)-based workshop plus usual care (n = 202)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Usual care alone (wait-listed control group, n = 201)
Number of subjects: 403
Study: 34325050

Group type: EXPERIMENTAL
Intervention: Positive screening for gout
Number of subjects: 4916

Group type: EXPERIMENTAL
Intervention: De novo diagnoses of gout
Number of subjects: 4916

Group type: EXPERIMENTAL
Intervention: Weighted prevalence of gout
Number of subjects: 4916
Study: 33508495

Group type: EXPERIMENTAL
Intervention: COC users (Microgynon®) during day 15-16 of pill consumption (PC2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: COC users (Microgynon®) during day 2-3 of pill consumption (PC1)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Eumenorrheic women
Number of subjects: 28
Study: 34766424

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 33126375

Group type: EXPERIMENTAL
Intervention: Anterior minimally invasive oblique retroperitoneal approach (ORA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Posterior transpedicular approach (PTA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Postoperative pain score
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Physical recovery
Number of subjects: 50
Study: 33536154

Group type: EXPERIMENTAL
Intervention: Pharmacist-led transitions of care program
Number of subjects: 88

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 88
Study: 32246696

Group type: EXPERIMENTAL
Intervention: 3D miniplates (2.0‐mm titanium plates)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2D miniplates (2.0‐mm titanium miniplate)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3D miniplates
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2D miniplates
Number of subjects: 120
Study: 35728068

Group type: EXPERIMENTAL
Intervention: mentoring + mindfulness
Number of subjects: 49

Group type: COMPARATOR
Intervention: mentoring-as-usual
Number of subjects: 49
Study: 32407717

Group type: EXPERIMENTAL
Intervention: High-risk group (HRG)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Preeclampsia group (PEC)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Research model parameters
Number of subjects: 87